Catalent Inc (CTLT) - News Archive

Catalent s $25 Million Expansion Elevates European Clinical Supply Expertise in Schorndorf Catalent, Inc. (NYSE: CTLT), a global leader in enabling the development and supply of better treatments for patients worldwide,...

Catalent, Inc. (NYSE: CTLT), the global leader in facilitating the development and supply of innovative treatments for patients worldwide, has recently released its fifth annual Corporate Responsibility Report for fisca...

In a recent press release, Catalent Inc. (NYSE: CTLT), a globally renowned company specializing in developing and supplying advanced treatments for patients worldwide, and Novo Holdings, a leading investment firm respon...

Catalent, a leading global provider of solutions for the pharmaceutical and healthcare industries, has made a significant commitment to reducing greenhouse gas (GHG) emissions. The company aims to achieve a 42% reductio...

In an effort to fortify its position as the global leader in developing and providing advanced treatments for patients worldwide, Catalent, Inc. recently announced a significant financial move. The company s wholly owne...

On Tuesday, October 31st, 2023, the stock market experienced a significant sell-off, triggered primarily by weakness within the Construction and Mining Machinery industry. This industry saw a decline...

In today's stock market report, we witness a promising start to the day as the market enters the green, following notable gains on Monday. The healthcare sector and consumer non-cyclical sector have...